Quest Diagnostics Incorporated(DGX)

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Latest News & Analysis
Quest Diagnostics (DGX): Innovation, AI, and Market Analysis
Quest Diagnostics (DGX) navigates market shifts with strategic innovation, AI integration, and expanding diagnostic services, despite a recent stock dip.
Quest Diagnostics (DGX): AI, Partnerships, and the Future of Diagnostics
Quest Diagnostics (DGX) is strategically positioned for future growth through AI integration, expansion into early cancer detection, and strategic acquisitions.
Quest Diagnostics (DGX): Growth Strategy and Market Analysis
Quest Diagnostics is strategically positioned for growth through market expansion, advanced diagnostics, and partnerships, driving long-term shareholder value.
DGX Analysis: Quest Diagnostics' Growth Strategy and Market Position
Quest Diagnostics (DGX) is strategically expanding its diagnostic capabilities through acquisitions, partnerships, and innovation, positioning itself for future growth.
Quest Diagnostics (DGX): Developments, Market Impact, and Outlook
Quest Diagnostics (DGX) navigates growth via strategic acquisitions and advanced diagnostics amidst debt management and healthcare policy shifts. Investor Day 2025 insights awaited.
Quest Diagnostics (DGX): Strategic Acquisitions, Investor Day Preview, and Market Outlook
Quest Diagnostics (DGX) navigates strategic acquisitions, innovation, and an upcoming Investor Day, shaping its diagnostic leadership and market outlook.
Quest Diagnostics: Strategic Acquisitions, Cancer Detection, and Investor Day Preview
Quest Diagnostics expands through strategic acquisitions and partnerships, focusing on cancer and Alzheimer's diagnostics. Investor Day preview and financial analysis included.
Quest Diagnostics: Strategic Expansion, Innovation, and Future Outlook
Quest Diagnostics strategically expands through acquisitions, partnerships, and innovation in Alzheimer's and cancer diagnostics. Investor Day 2025 promises insights into future strategies.
Quest Diagnostics: Strategic Acquisitions, Cancer Detection, and Market Outlook
Quest Diagnostics strategically expands with Spectra Laboratories acquisition and GRAIL partnership, innovating in Alzheimer's diagnostics. Investor Day insights awaited.
Quest Diagnostics: Innovation and Leadership 2025
Comprehensive update on DGX's latest innovations, strategic partnerships, Q4 earnings, and market trends driving diagnostic growth.
Quest Diagnostics: Market Trends, Innovation, and Future Outlook
Quest Diagnostics navigates market dynamics with strategic collaborations and innovation, focusing on growth in diagnostics and Alzheimer's research.